![]() This follows provisional approval by the TGA and a recommendation by the Australian Technical Advisory Group on Immunisation (ATAGI). The Comirnaty (Pfizer) vaccine is now being given to 5-11 year olds in Australia. The most commonly reported reactions are chest pain, headache, dizziness, nausea and fever. To 30 January 2022, we have received about 3,300 reports from approximately 3.2 million doses of Comirnaty (Pfizer) and Spikevax (Moderna) in 12-17 year olds. The TGA is closely monitoring reports in people aged under 18 years. Vaccine safety in children and adolescents If you or your child starts to feel faint before, during or after receiving the vaccine, make sure you are sitting or lying down to avoid falling and injuring yourself, and let the healthcare professional know. It is important to make sure you or your child has had enough to eat and drink before getting vaccinated as fainting may be more common when someone has an empty stomach or is not adequately hydrated. These side effects are usually mild and get better relatively quickly. Fainting was commonly reported following the human papillomavirus vaccine Gardasil in teenagers. Dizziness and fainting with vaccinationĭizziness, feeling faint and fainting are well-recognised stress-related reactions that sometimes occur following procedures involving an injection, including vaccination. Dizziness, feeling faint and fainting (also known as syncope) are also quite commonly reported with vaccination. The most frequently reported side effects suspected to be associated with the vaccines include injection-site reactions, such as a sore arm, headache, muscle and joint pain, fever and chills. Learn more about how to report a suspected side effect to a COVID-19 vaccine. by calling the NPS MedicineWise Adverse Medicine Events phone line for consumers.Learn more about how the TGA identifies and responds to safety issues.Īnyone can report a suspected side effect, either: However, new information on a case of suspected TTS reported late last year in a 78-year-old man from Victoria indicates that it now fits the criteria of probable TTS related to a first dose of Vaxzevria. No new cases of vaccine-related TTS have been reported since 16 December 2021.Our analysis shows it is reported in about 2 in every 100,000 vaccinated people following the first dose and 0.3 in every 100,000 vaccinated people after the second dose. ![]() ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |